GSK Clinches $2.8B HGSI Takeover; FDA Spied on Its Own - July 16, 2012

Having trouble viewing this email? View in Browser.

Monday, July 16, 2012  |   |   |   |  Increase the odds of identifying a functional biomarker pattern using our comprehensive protein biomarker services. Please click here for more information.   •  GlaxoSmithKline (GSK) Clinches $2.8 Billion Human Genome Sciences, Inc. (HGSI) Takeover More... •  FDA Spied on Its Own More... •  TPG Buying Par Pharmaceutical Companies, Inc. (PRX) for About $1.84 Billion More... •  Thermo Fisher Scientific (TMO) Agrees to Buy One Lambda, Inc. for $925 Million Cash More... •  Raleigh Startup, Sprout Pharmaceuticals Raises $20 Million in Search of "Female Viagra" More... •  Juventas Therapeutics, Inc. Raises $22.2 Million Series B Financing More... •  Hospira, Inc. (HSP) Recalls Cancer Drugs for Glass Particles More... •  AstraZeneca PLC (AZN)'s Ex-CEO Forfeits 2012 Bonus More... More Top News The Jackson Laboratory: In Vivo Pharmacology Services Rely on our unmatched expertise in efficacy studies to accelerate your drug discovery research. Our in vivo pharmacology testing services are fast, flexible, and supported by our 80-year history in mouse-based research. For more information, please visit: http://jaxservices.jax.org/invivo/index.html. •  If It Survives, DNA Sequencing Factory Could Be Future More... •  Chemicals in Cosmetics May Spike Diabetes Risk, Brigham and Women's Hospital Study More... •  Slower Walking Speed a Sign of Dementia, Mayo Clinic Study More... •  Company Looking to Market Genetically Modified Apples Runs Into Opposition, OKanagan Reveals More... •  New Proteins to Clear the Airways in Cystic Fibrosis and COPD, University of North Carolina Study More... •  Differences in Twins' DNA Set in the Womb, Murdoch Children's Research Institute Study More... •  Brain From Football Star to Be Studied for Damage, National Institutes of Health (NIH) Reveals More... •  New Gene Mutations Linked to ALS and Nerve Cell Growth Dysfunction , University of Massachusetts Medical School Study More...   More Featured News 8th Annual Bioassays and Bioanalytical Method Development October 1 - 3, 2012 Event Website IIR's 8th Annual Bioassays and Bioanalytical Method Development event (formerly Cell Based Assays and BAMD) gives you access to the know how of the pharmaceutical scientists with the most experience in cell-based and ligand binding assays and bio analytical method development. For more information, please visit: www.bioassaysevent.com • Pharm Country (Basking Ridge, New Jersey) ProEd Communications, Inc. Head, Global Regulatory Affairs Will be responsible and accountable for leading the continued success and growth of our regulatory business. The position requires an individual who is a strategic and critical thinker, has an intimate knowledge of drug/biologic/and preferably device approvals, has strong leadership abilities, and exhibits the flexibility necessary for working on diverse projects and traveling to client/FDA meetings. • Pharm Country (Woodcliff Lake, New Jersey) Eisai Inc. Director, Product Marketing, Epilepsy Franchise Responsible for creating and overseeing the implementation of all marketing strategies for Eisai's Epilepsy brand portfolio. To this end, you will ensure that the epilepsy franchise attains all of its sales and profit goals that are aligned to the strategic direction of the Company's business goals. • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Associate Director Global Knowledge Integration Will provide input and expertise in the development of, and successfully implement Takeda Global KM strategy. Serve as the change management lead for the Global Knowledge Management (GKM) organization. • BioCapital (Gaithersburg, Maryland) MedImmune, LLC Senior Manager, Quality Systems Responsible for providing Quality management for activities relating to MedImmune Quality Systems. Provide vision, leadership, coordination and advocacy for the identification, development, implementation of policies and procedures in support of the Company's Quality Systems, business plans and in coordination with other staff members and senior management. • Genetown (Lexington, Massachusetts) Cubist Pharmaceuticals, Inc. Senior Manager, Regulatory CMC Manages all CMC regulatory activities for assigned drug development projects. This includes providing Regulatory CMC consultation and guidance to project teams, driving Agency interactions, preparation and submission of CMC sections of regulatory dossiers in development teams, liaising with external CMC regulatory authorities as needed. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! 2012 Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ September 13, 2012 • Biotech Beach Career Fair, San Diego, CA September 20, 2012 • Biotech Bay Career Fair, Burlingame, CA October 3, 2012 • BioCapital Career Fair, Bethesda, MD October 9, 2012 • BioMidwest Career Fair, Lincolnshire, IL October 22, 2012 • Bio NC Career Fair, Durham, NC October 25, 2012 • Genetown Career Fair, Cambridge, MA November 5, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Strategies for Entering the Biosimilars Market • Appreciate the regulatory, clinical, and commercial expertise required to participate in the biosimilars market segment. • Identify the main competitors in the biosimilars industry and gain insight into their differing biosimilar strategies. • Assess the benefits of partnerships and alliances in gaining market entry. Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Nektar Therapeutics (AL) 490 Discovery Drive Huntsville, Alabama 35806 U.S.A. Phone: 256-533-4201 Fax: 256-533-4805 Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its proprietary polymer conjugation technology platform. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. More Company Profiles FREE Subscription to Biophotonics International Biophotonics International delivers a unique global insight into the photonic products and techniques that solve problems for researchers, product developers, clinical users, physicians and others actively involved in the field of medicine and biotechnology. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.